15 April 2013

Supreme Court to hear oral arguments in Myriad case

Myriad Genetics will deliver an oral argument at the US Supreme Court today (Monday, April 15) defending its patents covering isolated human gene sequences linked to breast and ovarian cancer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

Australian court backs Myriad in human gene patent dispute

18 February 2013 A judge at Australia’s Federal Court has upheld Myriad Genetics’ patent covering a human gene mutation linked to breast cancer, in the country’s first court ruling on whether isolated genes can be patented.

Patents

US Supreme Court remands Myriad patent ruling

1 June 2012 In light of its decision in Prometheus v Mayo, the US Supreme Court has remanded the Myriad Genetics patent case to the US Court of Appeals for the Federal Circuit.

Foley adds five-partner team from Perkins Coie and K&L Gates

Cahill expands practice with three-partner team from King & Spalding

Why US patent reform is ‘essential’ for US economic prosperity and security

Polsinelli steps up trade practice with hire of former ITC general counsel

Lululemon counsel on why Nike's 'Flyknit' claim construction faltered

Sterlington expands patent litigation team with new hire

Consulting firm adds economic analysts to its IP group

Nokia intensifies global patent fight with ITC complaint against Asus, Acer, and Hisense

Supreme Court to hear oral arguments in Myriad case

More on this story

Editor's picks

Editor's picks

More articles